Family · Pharmaceutical analytical standards

Baricitinib

A Janus kinase (JAK1 and JAK2) inhibitor, approved in Europe in 2017 for rheumatoid arthritis; in the United States it was later also authorised for severe alopecia areata and for some patients hospitalised with COVID-19. This family brings together the active ingredient, labelled standards, nitrosamines and other impurities.

Did you know?In February 2020 an artificial intelligence system linking information mined from the scientific literature flagged it as a possible treatment for COVID-19: the hypothesis was published in The Lancet.

Go to the active ingredient →

Active ingredientBaricitinibCat. No. P-B011-001CAS 1187594-09-7

Isotopically labelledBaricitinib-d5Cat. No. P-B011-002CAS 1564241-79-7

NitrosamineN-Nitroso Baricitinib Impurity 1Cat. No. P-B011-003

ImpurityBaricitinib Impurity 1Cat. No. P-B011-004CAS 1029716-44-6

Impurity1-(1-Ethoxyethyl)pyrazole-4-boronic AcidCat. No. P-B011-005CAS 2227194-01-4

Impurity1-(3-aminopropyl)azepan-2-oneCat. No. P-B011-006CAS 24566-95-8

Impurity1-(Ethylsulfonyl)azetidin-3-oneCat. No. P-B011-007CAS 1401222-91-0

Impurity1H-Pyrazol-4-olCat. No. P-B011-008CAS 4843-98-5

Impurity2-[1-(Ethylsulfonyl)azetidin-3-ylidene]acetonitrileCat. No. P-B011-009CAS 1187595-85-2

ImpurityBaricitinib Impurity 2Cat. No. P-B011-010CAS 941685-26-3

Impurity2-Chloro-7H-pyrrolo[2,3-d]pyrimidineCat. No. P-B011-011CAS 335654-06-3

Impurity4,4'-Bi-1H-pyrazoleCat. No. P-B011-012CAS 25240-33-9

ImpurityBaricitinib Impurity 3Cat. No. P-B011-013CAS 1911644-33-1

ImpurityBaricitinib Impurity 4Cat. No. P-B011-014CAS 269410-08-4

ImpurityBaricitinib Impurity 5Cat. No. P-B011-015CAS 952518-97-7

ImpurityBaricitinib Impurity 6Cat. No. P-B011-016CAS 2166596-69-4

ImpurityBaricitinib Impurity 7Cat. No. P-B011-017CAS 1000518-93-3

ImpurityAzetidinyl BaricitinibCat. No. P-B011-018CAS 2402776-84-3

ImpurityBaricitinib Acid ImpurityCat. No. P-B011-019CAS 2271228-52-3

ImpurityBaricitinib Impurity 8Cat. No. P-B011-020CAS 2271228-51-2

ImpurityBaricitinib Impurity 9Cat. No. P-B011-021

ImpurityBaricitinib Impurity 10Cat. No. P-B011-022

ImpurityBaricitinib Impurity 11Cat. No. P-B011-023

ImpurityBaricitinib Impurity 12Cat. No. P-B011-024

ImpurityBaricitinib Impurity 13 Sodium SaltCat. No. P-B011-025

ImpurityBaricitinib Impurity 14Cat. No. P-B011-026

ImpurityBaricitinib Impurity 15 HydrochlorideCat. No. P-B011-027CAS 2641097-39-2

ImpurityBaricitinib Impurity 16Cat. No. P-B011-028

ImpurityBaricitinib Impurity 17Cat. No. P-B011-029CAS 1643967-75-2

ImpurityBaricitinib Impurity 18Cat. No. P-B011-031CAS 1187595-90-9

ImpurityBaricitinib Impurity 19Cat. No. P-B011-032CAS 1187595-89-6

ImpurityBaricitinib Impurity 20Cat. No. P-B011-033

ImpurityBaricitinib Impurity 21Cat. No. P-B011-034

ImpurityBaricitinib Impurity 22Cat. No. P-B011-035

ImpurityBaricitinib Impurity 23Cat. No. P-B011-037

ImpurityBaricitinib Impurity 24Cat. No. P-B011-038CAS 1187594-16-6

ImpurityBaricitinib Impurity 25Cat. No. P-B011-039CAS 2910813-45-3

ImpurityBaricitinib Impurity 26Cat. No. P-B011-040CAS 2055723-13-0

ImpurityBaricitinib Impurity 27Cat. No. P-B011-041

ImpurityBaricitinib Impurity 24 HCl SaltCat. No. P-B011-042CAS 2497340-56-2

ImpurityBaricitinib Impurity 28Cat. No. P-B011-043CAS 2964606-42-4

ImpurityBaricitinib Impurity 29Cat. No. P-B011-044CAS 2964606-44-6

ImpurityBaricitinib Methyl EsterCat. No. P-B011-045CAS 2402776-80-9

ImpurityBaricitinib Impurity 30Cat. No. P-B011-047CAS 1236033-21-8

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.

See our services Contact us